RSV‐hRV co‐infection is a risk factor for recurrent bronchial obstruction and early sensitization 3 years after bronchiolitis

RSV‐hRV co‐infection is a risk factor for recurrent bronchial obstruction and early... INTRODUCTIONBronchiolitis is the most common cause of lower respiratory infection in the first year of life. Although most children with bronchiolitis have mild disease and are managed at home, infants admitted to hospital for the condition almost always have severe symptoms. The clinical relevance of the identification of the specific pathogens or combination of pathogens infecting a child remains unclear. However, children with human rhinovirus (hRV) may have different short‐ and long‐term outcomes compared to children with respiratory syncytial virus (RSV). We showed that clinical severity was not correlated with the level of serum Krebs von den Lungen 6 antigen (KL‐6), a biomarker of epithelial dysfunction, in previously healthy children, which indicates that the various clinical outcomes depend more on the adaptive capacities of the host rather than the intensity of epithelial dysfunction. Prediction of the risk of recurrent wheezing or long‐term asthma from the first year of life can be challenging. Against this background, we decided to prospectively follow a cohort of infants with an early episode of acute bronchiolitis, either hospitalized or cared for at home. Our main objective was to assess the risk factors for developing symptoms of recurrent bronchial obstruction during a 3‐year follow‐up after http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Medical Virology Wiley

RSV‐hRV co‐infection is a risk factor for recurrent bronchial obstruction and early sensitization 3 years after bronchiolitis

Loading next page...
 
/lp/wiley/rsv-hrv-co-infection-is-a-risk-factor-for-recurrent-bronchial-55CfkFRel1
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
© 2018 Wiley Periodicals, Inc.
ISSN
0146-6615
eISSN
1096-9071
D.O.I.
10.1002/jmv.25037
Publisher site
See Article on Publisher Site

Abstract

INTRODUCTIONBronchiolitis is the most common cause of lower respiratory infection in the first year of life. Although most children with bronchiolitis have mild disease and are managed at home, infants admitted to hospital for the condition almost always have severe symptoms. The clinical relevance of the identification of the specific pathogens or combination of pathogens infecting a child remains unclear. However, children with human rhinovirus (hRV) may have different short‐ and long‐term outcomes compared to children with respiratory syncytial virus (RSV). We showed that clinical severity was not correlated with the level of serum Krebs von den Lungen 6 antigen (KL‐6), a biomarker of epithelial dysfunction, in previously healthy children, which indicates that the various clinical outcomes depend more on the adaptive capacities of the host rather than the intensity of epithelial dysfunction. Prediction of the risk of recurrent wheezing or long‐term asthma from the first year of life can be challenging. Against this background, we decided to prospectively follow a cohort of infants with an early episode of acute bronchiolitis, either hospitalized or cared for at home. Our main objective was to assess the risk factors for developing symptoms of recurrent bronchial obstruction during a 3‐year follow‐up after

Journal

Journal of Medical VirologyWiley

Published: Jan 1, 2018

Keywords: ; ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off